Search for a trial

Convalescent Antibody-Mediated Treatment of COVID-19 Infections in Patients with B-cell dysfunction, a Randomized Trial (COVID-Compromise Study).

There have been reports of a more serious course of COVID-19 infections in patients with a reduced immune system, such as patients with congenital immune disorders, (haematological) malignancies or patients taking medications that suppress the…

Blood-borne assessment of stromal activation in esophageal
adenocarcinoma to guide tocilizumab therapy: a randomized
phase II proof-of-concept study

This study has been transitioned to CTIS with ID 2023-509458-77-00 check the CTIS register for the current data. The primary objective of the study of this study is to demonstrate that stroma-targeting by tocilizumab in esophageal adenocarcinoma…